Back

One-pot CRISPR diagnostics for the rapid detection of Candida species and antimicrobial resistance biomarkers

Heathcote, A.; Bird, M.; Jeong, H.; Li, X.; Kozak, R.; Weckman, N. E.

2026-09-09 infectious diseases
10.64898/2026.09.01.26361059 medRxiv
Show abstract

Antimicrobial resistance (AMR) is a growing public health threat, where drug-resistant Candida infections are associated with increased hospital costs, lengths of stay, and high mortality rates. Current diagnostic methods are slow and labor-intensive, causing delays in diagnosis and patient treatment. In this research, we propose a rapid CRISPR-based diagnostic for identifying Candida pathogens and antifungal resistance biomarkers in clinical applications. One-pot CRISPR assay designs are optimized for three clinically relevant Candida species, achieving attomolar sensitivity with synthetic DNA and validating performance on cultured isolates. Strategies are developed to engineer CRISPR gRNA to control one-pot reaction kinetics, enhancing discrimination of single nucleotide polymorphism (SNP) resistance mutations associated with azole and echinocandin antifungals. This research expands our understanding of the design of one-pot CRISPR reactions for sensitive detection of DNA, while establishing a foundation for faster, more precise AMR diagnostics to improve surveillance and outbreak management of fungal infections.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.